Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates
- 31 May 1987
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 7 (2) , 119-126
- https://doi.org/10.1016/0732-8893(87)90029-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Beta-lactamase-mediated imipenem resistance in Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1986
- Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1986
- Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982Antimicrobial Agents and Chemotherapy, 1984
- β-Lactamase stability of cefoxitin in comparison with other β-lactam compoundsDiagnostic Microbiology and Infectious Disease, 1983
- Susceptibility of the Bacteroides fragilis group in the United States in 1981Antimicrobial Agents and Chemotherapy, 1983
- Inactivation of Cephalosporins by BacteroidesAntimicrobial Agents and Chemotherapy, 1979
- A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of post–cesarean section endomyometritisAmerican Journal of Obstetrics and Gynecology, 1979
- Factors Contributing to Resistance to Beta-Lactam Antibiotics in Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1979
- Cefoxitin Resistance to Beta-Lactamase: a Major Factor for Susceptibility of Bacteroides fragilis to the AntibioticAntimicrobial Agents and Chemotherapy, 1977
- Susceptibility of Anaerobes to Cefoxitin and Other CephalosporinsAntimicrobial Agents and Chemotherapy, 1975